Risk-sharing arrangements (RSAs), also known as managed entry agreements (MEAs), are often categorized as financial/non-health outcome or health outcome-based1. RSAs have been predominantly adopted in the pharmaceutical sector, though they are gaining traction also in the medical device industry, particularly in areas such as diabetes.